Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
41,175,457
-
Shares change
-
+802,260
-
Total reported value, excl. options
-
$3,775,678,943
-
Value change
-
+$79,685,163
-
Put/Call ratio
-
101%
-
Number of buys
-
85
-
Number of sells
-
-84
-
Price
-
$91.70
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q1 2018
206 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q1 2018.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,175,457 shares
of 65,000,000 outstanding shares and own 63% of the company stock.
Largest 10 shareholders include FMR LLC (6,531,199 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,468,567 shares), VANGUARD GROUP INC (3,382,055 shares), BlackRock Inc. (3,258,513 shares), WELLINGTON MANAGEMENT GROUP LLP (2,676,150 shares), OppenheimerFunds, Inc. (1,613,636 shares), LORD, ABBETT & CO. LLC (1,593,079 shares), STATE STREET CORP (1,555,523 shares), Hillhouse Capital Management, Ltd. (1,368,449 shares), and PERCEPTIVE ADVISORS LLC (1,030,434 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.